AIB Home (IRE)   fxcentre.com  fxcentre.co.uk   fxcenterusa.com   AIB Economics   AIB Home (GB) 

Thursday 30th October 2014 
email to a colleague

printer version
services
Product Description Product Description

Product Description
Sheets
Cash Management Cash Management

Cash Mgt Services
Public/Private Sectors
2013 Historic Rates 2013 Historic Rates

Historic Average
FX Rates 2013
Let us know let us know

send us your feedback
on fxcentre.com
RateSaver RateSaver

online historic fx and
interest rates
fx3 fx3

custom fx rates
directly to your mobile
fxcentre pro fxcentre pro

confirm and view deals
& payments online
Human Genome takeover by Glaxo SK
Monday, 16th July 2012 07.34am

Human Genome Sciences Inc has agreed to be acquired by GlaxoSmithKline Plc, subject to approval of some last-minute details, for about $14 a share in cash, two sources familiar with the situation said on Sunday.

The deal is expected to be announced before the U.S. stock market opens today, the sources added.

The price represents an increase to Glaxo's previous offer of $13 a share.

Human Genome shares ended trading on Friday at $13.58. ( C) Reuters

More breaking news >
The above information has been taken from sources we believe to be reliable and trustworthy. However the accurateness and completeness thereof are not guaranteed and therefore should not be relied upon as such. AIB does not endorse or approve the content of any information from third party sites nor will it have any liability in connection with any third party site (including but not limited to liability arising out of any allegation that the content of or information on any third party site infringes any law or the rights of any person or entity)
  © Allied Irish Banks, p.l.c. 2003 AIB Customer Treasury Services is a registered business name of Allied Irish Banks, p.l.c.
Allied Irish Banks, p.l.c. is regulated by the Central Bank of Ireland. Registered Office: Bankcentre, Ballsbridge, Dublin 4.
Registered in Ireland : Registered No. 024173.